The analysis of Mediator kinase expression in clinical cancers, together with prior reports (26), shows that CDK8 is downregulated and CDK19 upregulated in primary PCa, which we can now explain by the regulation of CDK8 and CDK19 expression by androgen signaling. Here, CDK8 is linked to cancer.